Delivery Order SPE2DB24D2100-SPE2DB25FBGMT
- Not listed
- The Defense Logistics Agency awarded a $2,320.49 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG Film 60s, a pharmaceutical product used for pain management. This competitively awarded contract, issued on August 25, 2025, carries a firm fixed price and is scheduled for ultimate completion on August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,872.48 delivery order to AmerisourceBergen Drug Corp for Belbuca 600 microgram films (60 count) under a firm fixed price contract type. The award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 900 MCG film (60 count) with a ceiling value of $1,791.88 under a firm fixed price contract type. This delivery order, awarded on August 29, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through full and open competition with no set-aside designation. Performance will be completed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.52 to AmerisourceBergen Drug Corp for BELBUCA 300 MCG Film (60 count) on July 25, 2025, with completion expected by July 28, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product is a buccal film formulation used for pain management, reflecting the company's role as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,301.11 delivery order to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60 count) under a firm fixed price contract. The order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of BELBUCA 450 micrograms film in a quantity of 60 units, valued at $1,301.28. This non-set-aside, firm fixed-price delivery order has an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belbuca 300 mcg film (60-count), with a ceiling value of $1,075.23. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a $1,301.28 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Belbuca 450 mcg film, with an ultimate completion date of September 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. Belbuca is a buccal film formulation used for pain management in opioid-tolerant patients. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 450 MCG Film in a quantity of 60 units, with a ceiling value of $1,053.12. This firm fixed price contract, awarded on July 23, 2025, represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating it was...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGMTDelivery Order
The Defense Logistics Agency awarded a $1,455.48 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 microgram film (60 count) on September 19, 2025, with completion targeted for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a critical pharmaceutical supplier to the Defense Logistics Agency's Medical Supply Chain, providing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. This delivery order for BELBUCA, a buccal film opioid formulation, exemplifies the company's role in supplying specialized pain management pharmaceuticals through the DLA's pharmaceutical procurement programs. The award is part of AmerisourceBergen's significant federal contract portfolio with DLA, supported by its $999,999,999.00 indefinite delivery contract running through December 2026, which enables flexible global pharmaceutical support across multiple therapeutic domains for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/19/25 |